SG Americas Securities, LLC - APREA THERAPEUTICS INC ownership

APREA THERAPEUTICS INC's ticker is APRE and the CUSIP is 03836J102. A total of 70 filers reported holding APREA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.12 and the average weighting 0.0%.

Quarter-by-quarter ownership
SG Americas Securities, LLC ownership history of APREA THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$2,920,000
-12.7%
598,395
-8.8%
0.01%
-22.2%
Q1 2021$3,345,000
+2834.2%
655,888
+2725.9%
0.02%
+1700.0%
Q4 2020$114,000
-84.6%
23,210
-24.3%
0.00%
-80.0%
Q3 2020$738,00030,6690.01%
Other shareholders
APREA THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Versant Venture Management, LLC 1,259,662$6,437,0002.66%
COASTAL INVESTMENT MANAGEMENT, L.P. 41,965$214,0000.30%
Redmile Group, LLC 694,918$3,551,0000.06%
Quantamental Technologies LLC 13,752$70,0000.05%
KENNEDY CAPITAL MANAGEMENT LLC 342,486$1,750,0000.04%
PDT Partners, LLC 87,734$448,0000.03%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 75,000$383,0000.01%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 49,100$251,0000.01%
NEXT Financial Group, Inc 11,347$58,0000.01%
Sugarloaf Wealth Management, LLC 1,500$8,0000.00%
View complete list of APREA THERAPEUTICS INC shareholders